Rare Diseases × Endocrine × Clear all
NCT02834013 2026-04-13

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

National Cancer Institute (NCI)

Phase 2 Active not recruiting
818 enrolled
NCT06573723 2026-01-14

Institutional Registry of Rare Diseases

Hospital Italiano de Buenos Aires

Recruiting
380 enrolled
NCT01793168 2025-05-29

CoRDS

Sanford Health

Recruiting
20,000 enrolled